Abstract
Introduction: Major depressive disorder is highly prevalent among medical students and strongly associated with cognitive dysfunctions.
Objective: To compare neuropsychological and electrophysiological profiles (P300 parameters) of medical students with and without depressive symptoms.
Methods: A cross-sectional and comparative study was conducted with 140 second-year medical students. Depressive symptoms were assessed with the Patient Health Questionnaire-9. Cognitive performance was evaluated with the Montreal Cognitive Assessment (MoCA) and CogniFit (CogniFit Inc., San Francisco, CA, USA) computerized tests. Event-related potentials were recorded through a standard auditory oddball paradigm, analyzing N100, N200, and P300 latency and amplitude. Statistical analyses included independent sample t-tests and analysis of variance, with significance set at p < 0.05. Effect sizes (Cohen’s d) were reported for all group comparisons, and appropriate corrections for multiple comparisons were applied to control type I error.
Results: Students with depressive symptoms exhibited slower response time (p < 0.01), processing speed (p = 0.01), impaired contextual memory (p =.01), short-term memory (p = 0.01), working memory (p = 0.01), focused attention (p = 0.01) and perception domain( p = 0.03). On the MoCA, lower in abstraction (p = 0.03), delayed memory recall (p < 0.01), and total MoCA score (p = 0.008). Event-related potentials analysis revealed significantly prolonged latencies for N100, N200, and P300 (all, p < 0.01), and decreased amplitudes in N100, N200, and P300 (p < 0.05). Prolonged event-related potentials latencies (particularly P300) correlated negatively with performance on processing speed (r = -0.39, p < 0.001), focused attention (r = -0.32, p < 0.001), and delayed recall (r = -0.31, p < 0.001).
Conclusions: Medical students with depressive symptoms demonstrate specific cognitive impairments and altered event-related potential markers, reflecting reduced attentional efficiency and information processing. Combining computerized neuropsychological testing with electrophysiological measures may provide a feasible screening pathway for cognitive vulnerability among medical trainees and guide the development of preventive and educational interventions within medical curricula.
Keywords: cognitive dysfunction, depression, event-related potentials, medical students, neuropsychology, p300
Introduction
Major depressive disorder (MDD) is a leading cause of disability worldwide, affecting nearly 5% of the global adult population [1]. Beyond affective and somatic symptoms, cognitive dysfunction has emerged as a central feature of depression, with deficits in executive functions, attention, working memory, and processing speed not being secondary, but rather core components that significantly impair functional recovery and quality of life [2-5]. Estimates suggest that 85-90% of patients experience cognitive impairment during acute depressive episodes, and nearly 40% continue to exhibit deficits even after clinical remission [6,7].
Cognitive dysfunction, defined as impairments in core mental processes such as attention, memory, executive functioning, and information processing, has critical implications for education and occupational performance [3,8]. Reduced processing speed, impaired executive functioning, and compromised memory may hinder academic achievement, occupational performance, and interpersonal relationships [8]. Persistent cognitive deficits are also strong predictors of relapse, poor treatment outcomes, and reduced psychosocial adjustment [9]. Therefore, the early identification of cognitive deficits in individuals with depressive symptoms is critical for improving functional prognosis.
Depression is a major public health challenge in the university context. The prevalence of depressive symptoms among higher-education students ranges from 25% to 35%, exceeding those reported in the general population [10,11]. Medical students face heightened vulnerability owing to long training hours, academic overload, constant evaluations, and exposure to stressful clinical environments. These conditions not only increase the risk of depressive disorders but also exacerbate cognitive difficulties, compromising both academic performance and professional development [12]. Previous studies have reported that depression in medical students is associated with higher rates of burnout, suicidal ideation, and academic dropout [10,13,14]. However, despite growing attention to student mental health, few studies have systematically examined how depressive symptoms interact with cognitive and neurophysiological processes in non-clinical young populations, such as medical students [15,16]. This limited evidence stands in contrast to the abundance of event-related potential (ERP)-based studies in clinical MDD samples, highlighting the need for early, subclinical biomarkers in educational contexts [17-21].
Despite the well-documented burden of depression among medical trainees, most investigations have focused on affective and somatic symptoms, with limited attention paid to cognitive and neurophysiological correlations [10,22]. While standardized neuropsychological tests provide valuable information about specific domains [4,7], they rely on subjective performance and are influenced by contextual variables, such as motivation or fatigue. In this regard, electrophysiological techniques offer an opportunity to obtain objective markers of cognitive function [17,19,20].
ERPs are time-locked electrophysiological responses derived from scalp EEG that reflect synchronous excitatory and inhibitory postsynaptic potentials generated by cortical pyramidal neurons [17,19,20]. They provide a non-invasive, inexpensive, and temporally precise method for examining neurocognitive processes relevant to psychopathology [17,20]. ERPs are commonly elicited using the auditory oddball paradigm, in which a continuous train of frequent auditory stimuli is intermittently interrupted by infrequent “rare” stimuli that differ in intensity or acoustic features [19]. These rare stimuli were presented in a randomized order to prevent predictability, maintain sustained attention, and avoid contingency effects associated with regular stimulus intervals. Importantly, P300 responses can also be elicited when a rare event consists of the omission of an expected frequent stimulus, underscoring the paradigm’s versatility in probing attentional and cognitive processing.
ERPs waveforms comprise multiple components indexing the distinct stages of information processing. Early components include the N100 (N1), which emerges around 100 ms and reflects initial sensory encoding and early selective attention, and the N200 (N2), which appears around 180-300 ms and is associated with executive control mechanisms such as stimulus evaluation, conflict monitoring, novelty detection, inhibitory control, and mismatch processing [23]. P300 (P3), a positive deflection peaking between 250-400 ms, is the most widely studied late component in depression research and reflects attentional allocation, working-memory updating, and context integration. It consists of two subcomponents: P3a, an earlier frontocentral peak occurring 250-300 ms and ~20-50 ms before P3b, which is maximal over parietal regions and peaks around 300-350 ms [17,19,20]. Quantitatively, the P300 amplitude represents the voltage difference (in μV) between the pre-stimulus baseline and the largest positive peak, indexing the neural resources devoted to stimulus processing, whereas latency reflects the time (in ms) to the peak and indicates processing speed [17,19,20].
The P300 component reflects neuroelectric responses to attention and working memory demands. Prolonged latency has been associated with slower cognitive processing, where reduced amplitude indicates a diminished allocation of attentional resources [24,25]. Evidence suggests that P300 alterations may be sensitive biomarkers of cognitive dysfunction in MDD [26-28].
However, data integrating both cognitive testing and ERP measures in medical students with depressive symptoms remains scarce [29]. At the time of the study, we did not find any studies that systematically compared neuropsychological profiles with electrophysiological parameters, despite their high relevance for early detection and preventive interventions. Such integration could provide novel insights into the mechanisms through which depressive symptoms could be one of the factors associated with academic performance, as well as inform tailored strategies to mitigate the long-term consequences of cognitive dysfunction within medical training.
Therefore, this study aimed to compare neuropsychological performance and electrophysiological parameters (specifically, the P300 component) between medical students with and without depressive symptoms. By combining standardized cognitive assessment with objective neurophysiological markers, this study sought to contribute novel evidence on the cognitive inefficiencies and attentional processing alterations associated with depressive symptoms in young, non-clinical populations, offering potential implications for early detection and preventive educational strategies.
Materials and methods
Study design and participants
This cross-sectional, comparative study was conducted between October 2022 and April 2023 among undergraduate medical students enrolled in the second year of a six-year medical program at a Mexican public university. Participants were recruited through institutional announcements and selected via non-probabilistic convenience sampling, an approach commonly used in educational and mental-health research because of logistical and feasibility constraints in university settings.
The inclusion criteria were (a) enrollment as a full-time medical student; (b) age between 18 and 25 years; and (c) right-handedness to ensure EEG consistency. Exclusion criteria included (a) history of neurological or psychiatric disorders (other than depressive symptoms screened in this study); (b) use of psychoactive medication, substances, or consumption of more than 200-300 mg of caffeine (approximately ≥2 cups of coffee) within 24 hours prior to testing; (c) sleep deprivation (<6 hours of sleep the night prior); and (d) uncorrected visual or auditory impairments.
Participants were classified into two groups, with and without depressive symptoms, based on validated cut-off scores from the Patient Health Questionnaire-9 (PHQ-9), where a score of ≥10 indicated clinically relevant depressive symptomatology [30,31]. The PHQ-9 was also used to determine symptom severity, following the established classifications: 0-4 (minimal), 5-9 (mild), 10-14 (moderate), 15-19 (moderately severe), and 20-27 (severe). The instrument demonstrated strong psychometric performance, with internal consistency coefficients (Cronbach’s α) of 0.86-0.89 and sensitivity and specificity values of approximately 0.88, supporting its validity for identifying depressive symptoms. All classifications were determined prior to cognitive and electrophysiological testing to avoid measurement bias [30,31].
Neuropsychological assessment
Cognitive performance was assessed using two complementary tools, the CogniFit (CogniFit Inc., San Francisco, CA, USA) Cognitive Assessment Battery (CAB) and Montreal Cognitive Assessment (MoCA).
CogniFit Cognitive Assessment Battery (CAB)
The CogniFit Cognitive Assessment Battery (CAB), is a validated computerized neuropsychological battery that evaluates more than 20 cognitive abilities across domains, including memory (short-term, working, contextual, and recognition), attention (focused, divided, and sustained), executive functions (planning, inhibition, updating, and flexibility), visuospatial perception, reaction time, and processing speed. The full assessment takes approximately 30-40 minutes. Raw scores were normalized for age and sex using standardized normative data, providing domain-specific indices. CogniFit has shown acceptable psychometric properties. In recent validation work, internal consistency (Cronbach’s α = 0.85-0.88) and test-retest reliability (r = 0.69-0.92) have been reported [32]. The battery is widely used in research and by health professionals to screen for cognitive strengths and weaknesses in diverse populations [33-35].
Montreal Cognitive Assessment (MoCA)
The Montreal Cognitive Assessment (MoCA) is a standardized screening instrument for global cognition covering attention, memory, executive functions, language, visuospatial abilities, and orientation, with total scores ranging from 0 to 30 points. Higher scores reflect better cognitive functioning, and a validated Spanish version was used [36]. A cutoff score of ≤25 was used to indicate possible cognitive impairment. This threshold is consistent with findings from the Mexican validation study by Aguilar-Navarro et al., which reported optimal sensitivity and specificity for detecting mild cognitive impairment using scores ≤26 in older adults, independent of age and education [36]. Given our younger, highly educated sample, the ≤25 cutoff provides an appropriate and conservative criterion aligned with the validated performance characteristics of the MoCA.
This dual assessment was selected to integrate the ecological validity of the MoCA with the domain precision of CogniFit, thus enabling a multidimensional understanding of cognitive efficiency and executive performance.
Electrophysiological assessment (event-related potential)
ERPs were recorded using a 32-channel electroencephalography (EEG) system, Cadwell EEG/EP system (Cadwell Industries, Kennewick, WA, USA) with a sampling rate of 1000 Hz, and electrode impedance was maintained below 5 kΩ, following the international 10-20 system. All recordings were conducted in an electrically and acoustically shielded room under dim lighting, with the participants seated comfortably. The procedure was explained to all the participants. Then, with all the necessary precautions, the electrodes were positioned on the scalp at positions Fz, Cz, and Pz, with linked mastoids as the reference and Fpz as the ground. Vertical and horizontal electrooculogram (EOG) channels were used to monitor eye movements.
The EEG data were first cleaned using a band-pass filter of 0.1-30 Hz to remove slow drifts and high-frequency noise. The continuous EEG was then divided into time segments (epochs) ranging from 100 ms before the stimulus to 800 ms after it. Each epoch was adjusted using a −100 to 0 ms baseline period to ensure that all segments started at a comparable voltage level. To reduce artifacts, ocular activity (blinks and eye movements) was identified and removed using independent component analysis (ICA). Any remaining epochs with excessive noise (greater than ±100 µV) were automatically excluded. After preprocessing, an average of 82-90% of all trials were retained, and every participant contributed at least 30 artifact-free target trials, providing a reliable signal-to-noise ratio for ERP analysis.
A standard auditory oddball paradigm was used, with 80% frequent tones (1000 Hz) and 20% infrequent target tones (1500 Hz) with a 1000 ms interstimulus interval. The participants were instructed to press a button when detecting the target tones. Stimuli were delivered in a pseudorandom sequence to prevent predictability, and the participant had to be attentive to the task at hand. This paradigm is widely accepted as the preferred procedure for eliciting the P300 component [19,20].
Analyses focused on the N100, N200, and P300 components, measured at the central (Cz) and parietal (Pz) electrodes. The peak latency (ms) and amplitude (µV) were extracted using semi-automatic detection windows (N100: 60-120 ms, N200: 150-250 ms, P300: 280-500 ms).
Special attention was given to the P300, which is typically elicited between 300 and 600 ms after infrequent stimuli, reflecting selective attention, stimulus evaluation, and working memory updating. Alterations in these parameters have been associated with cognitive dysfunction in psychiatric disorders, including major depression.
All cognitive and electrophysiological assessments were performed at the Learning and Mental Health Sciences Laboratory under controlled lighting, temperature, and noise conditions to minimize external interference with signal quality and cognitive performance. The Committee on Ethics and Research, National Autonomous University of Mexico, approved the study protocol FM/DI/056/2021, and all participants provided written informed consent prior to enrollment. The study was conducted in accordance with the Declaration of Helsinki and adhered to international ethical principles for research involving human subjects.
Statistical analysis
Data normality was confirmed using Shapiro-Wilk tests, and homogeneity of variances was confirmed using Levene’s test. Independent-sample t-tests and one-way ANOVA were used to compare neuropsychological and ERP parameters between groups. Effect sizes are reported as Cohen’s d with 95% confidence intervals (CIs).
Correlation analyses between cognitive performance and ERP measures (latency and amplitude) were conducted using Pearson’s r, controlling for age and sex. Statistical significance was set at p < .05 (two-tailed), with false discovery rate (FDR) correction applied to control for multiple comparisons. All analyses were conducted using IBM SPSS Statistics (version 24.0; IBM Corp., Armonk, NY, USA).
To evaluate robustness, post-hoc power analyses (G*Power 3.1, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany) indicated that the achieved sample size (n = 140) provided >0.90 power to detect medium effect sizes (d = 0.50) at α = 0.05.
Results
A total of 140 second-year medical students participated in the study (mean age = 21.0 ± 1.6 years), of whom 60.7% (n = 85) were female subjects. The majority were single (97.1%) and lived with their family (96.4%). No significant differences were observed between groups with and without depressive symptoms regarding age, sex, or socioeconomic status (all p > 0.05), ensuring comparability across groups.
Among participants with depressive symptoms, 74.3% (n = 52) scored in the moderate-to-severe range, and 25.7% (n = 18) were classified as having mild depression (Table 1).
Table 1. Sociodemographic and clinical characteristics of the sample.
*χ² = chi-square test for categorical variables; **t = Student’s t-test for continuous variables.
| Variable | Total n (%) | Without depressive symptoms n (%) | With depressive symptoms n (%) | Statistics |
| Total | 140 | 70 | 70 | – |
| Sex | ||||
| Women | 85 (60.7) | 47 (61.4) | 38 (54.2) | p = 0.12* |
| Men | 55 (39.3) | 23 (38.6) | 32 (45.8) | |
| Age (years, M ± SD) | 21.6 ± 1.06 | 21.6 ± 1.01 | 21.7± 1.11 | p = 0.50** |
| Relationship status | ||||
| Without partner | 136 (97.1) | 67 (95.7) | 69 (98.5) | p = 0.31* |
| With partner | 4 (2.9) | 3 (4.3) | 1 (1.5) | |
| Living arrangement | ||||
| With family | 135 (96.4) | 68 (97.1) | 67 (95.7) | p = 0.64* |
| Without family | 5 (3.6) | 2 (2.9) | 3 (4.3) | |
| Financial resources | ||||
| Sufficient | 101 (72.1) | 50 (71.4) | 51 (72.8) | p = 0.85* |
| Insufficient | 39 (27.9) | 20 (28.6) | 19 (27.2) | |
| Degree of depression | ||||
| None | 70 (50) | 70 (100) | 0 (0) | – |
| Mild | 0 (0) | 0 (0) | 0 (0) | |
| Moderate | 27 (19.6) | 0 (0) | 27 (38.6) | |
| Moderately severe | 25 (17.9) | 0 (0) | 25 (35.7) | |
| Severe | 18 (12.5) | 0 (0) | 18 (25.7) | |
Electrophysiological correlates (ERPs)
Table 2 presents a comparison of the ERP components between students with and without depressive symptoms. Students with depressive symptoms exhibited systematic alterations in the ERP components. Latency measures were significantly prolonged for N100 (M = 95.5 ± 8.9 ms) compared to controls (M = 78.4 ± 8.5 ms; t = 11.63, p < 0.001, d = 2.0), for N200 (M = 198.7 ± 14.0 ms vs. 169.9 ± 14.8 ms; t = 11.77, p < 0.01, d = 2.0), and for P300 (M = 309.6 ± 13.8 ms vs. 280.5 ± 15.7 ms; t = 11.63, p < 0.01, d = 2.0).
Table 2. ERP latency and amplitude measures between students with and without depressive symptoms.
Latency values are expressed in milliseconds (ms), and amplitude values are expressed in microvolts (µV). Student’s t-test was used for between-group comparisons.
ERP = electrophysiological correlate.
| ERP component | Measure | Without depressive symptoms (M ± SD) | With depressive symptoms (M ± SD) | t | p-value | Cohen's d |
| N100 | Latency (ms) | 78.4 ± 8.5 | 95.5 ± 8.9 | 11.63 | <0.001 | 2.0 |
| Amplitude (µV) | -2.95 ± 1.09 | -2.23 ± 0.84 | -4.37 | <0.001 | 0.7 | |
| N200 | Latency (ms) | 169.9 ± 14.8 | 198.7 ± 14.0 | 11.77 | <0.01 | 2.0 |
| Amplitude (µV) | -4.45 ± 1.50 | -3.36 ± 1.06 | -4.93 | <0.001 | 0.8 | |
| P300 | Latency (ms) | 280.5 ± 15.7 | 309.6 ± 13.8 | 11.63 | <0.01 | 2.0 |
| Amplitude (µV) | 9.59 ± 3.59 | 8.17 ± 3.24 | 2.44 | 0.016 | 0.4 |
Amplitude values were also reduced in students with depressive symptoms for N100 (-2.23 ± 0.84 µV vs. -2.95 ± 1.09 µV; t = -4.37, p < 0.001, d = 0.7), N200 (-3.36 ± 1.06 µV vs. -4.45 ± 1.50 µV; t = -4.93, p < 0.001, d = 0.8), and P300 (8.17 ± 3.24 µV vs. 9.59 ± 3.59 µV; t = 2.44, p = 0.016, d = 0.4).
These findings demonstrated a consistent pattern of slowed neural processing and reduced allocation of attentional resources among students with depressive symptoms. The large effect sizes observed for latency variables suggest a robust neurophysiological divergence between groups. Figure 1 illustrates a comparison of ERPs between students with and without depressive symptoms, showing clear latency delays (Figure 1A) and amplitude reductions (Figure 1B) in students with depressive symptoms.
Figure 1. Latency and amplitude of N100, N200, and P300 components in medical students with and without depressive symptoms.
(1A) Group differences in ERP latencies for N100, N200, and P300 components. Values represent mean latencies (ms) with corresponding p-values derived from independent-sample t-tests. Students with depressive symptoms showed a significantly prolonged latency across all components.
(1B) Group differences in ERP amplitudes for N100, N200, and P300 components. Bars depict mean amplitudes (µV); p-values were obtained using independent-samples t-tests. Students with depressive symptoms demonstrated significantly reduced amplitudes across all ERP components.
ERP = electrophysiological correlate.
Global cognition (MoCA)
On the Montreal Cognitive Assessment (MoCA), no significant group differences were found in visuospatial/executive function, attention, language, or orientation (all p > 0.05). However, students with depressive symptoms scored significantly lower in abstraction (1.75 ± 0.44 vs. 1.88 ± 0.32; t(138) = 2.11, p =0.03, d = 0.4), delayed memory recall (2.67 ± 1.17 vs. 3.52 ± 1.28; t(138) = 4.13, p < 0.01, d = 0.7), and total MoCA score (22.75 ± 2.28 vs. 23.88 ± 2.69; t(138) = 2.68, p = 0.008, d = 0.5) (Table 3).
Table 3. Comparison of MoCA cognitive domains between students with and without depressive symptoms.
Values represent the mean (M) ± standard deviation (SD). Higher scores indicated better cognitive performance. Interpretation of Cohen’s d: 0.20 = small, 0.50 = medium, 0.80 = large.
MoCA: Montreal Cognitive Assessment
| Cognitive domain | Without depressive symptoms | With depressive symptoms | Statistics | Cohen’s d |
| Visuospatial | 3.76 (1.140) | 3.70 (1.115) | t=0.340, p=0.734 | 0.05 |
| Identification | 2.99 (0.487) | 2.93 (0.468) | t=-0.020, p=0.984 | 0.5 |
| Attention | 3.97 (1.483) | 3.67 (1.390) | t=-1.256, p=0.211 | 0.15 |
| Language | 1.96 (0.836) | 1.88 (0.850) | t=0.517, p=0.606 | 0.10 |
| Abstraction | 1.88 (0.323) | 1.75 (0.438) | t=2.111, p= 0.03 | 0.35 |
| Memory | 3.52 (1.275) | 2.67 (1.172) | t=4.126, p=<0.01 | 0.7 |
| Orientation | 5.94 (0.374) | 5.97 (0.169) | t=-0.555, p=0.58 | 0.10 |
| Total | 23.88 (2.69) | 22.75 (2.28) | t=2.683, p=0.008 | 0.45 |
Table 3 also displays the effect sizes (Cohen’s d) and statistical significance for each domain of the MoCA when comparing students with and without depressive symptoms. While most domains showed negligible or non-significant differences, students with depressive symptoms performed significantly worse in abstraction, memory, and total MoCA scores, with small to moderate effect sizes.
Specific cognitive processes (CogniFit)
Table 4 presents the comparative neuropsychological assessment using CogniFit, and significant differences were observed between the groups with and without depressive symptoms in multiple cognitive domains. Students with depression scored significantly lower in planning (68.31 ± 16.34 vs. 76.90 ± 15.04; p = 0.01, d = 0.6) and processing speed (66.86 ± 18.24 vs. 82.74 ± 11.16; p = 0.01, d = 1.0), reflecting a generalized slowing in the execution of cognitive tasks. They also performed worse on contextual memory (63.66 ± 21.24 vs. 74.94 ± 21.32; p = 0.01, d = 0.5), short-term memory (62.30 ± 19.72 vs. 74.39 ± 16.99; p = 0.01, d = 0.7), and working memory (62.67 ± 18.51 vs. 75.57 ± 17.83; p = 0.01, d = 0.7).
Table 4. Comparison of CogniFit cognitive domains between students with and without depressive symptoms.
M = mean; SD = standard deviation. Comparisons based on independent-sample t-tests. Cohen’s d reflects the magnitude of effect size. Interpretation of Cohen's d: 0.20 = small, 0.50 = medium, 0.80 or greater = large.
| Cognitive domain | Without depressive symptoms | With depressive symptoms | Statistics | Cohen's d |
| Planning | 76.90 (15.04) | 68.31 (16.34) | t=3.235 p=0.01 | 0.6 |
| Processing speed | 82.74 (11.16) | 66.86 (18.24) | t=6.214 p=0.01 | 1 |
| Cognitive flexibility | 77.20 (18.57) | 74.93 (17.00) | t=0.755 p=0.452 | 0.15 |
| Short-term phonological memory | 68.26 (22.13) | 62.54 (21.23) | t=1.559 p=0.121 | 0.53 |
| Contextual memory | 74.94 (21.32) | 63.66 (21.24) | t=3.137 p=0.01 | 0.5 |
| Naming | 71.06 (21.56) | 68.59 (22.44) | t=0.664 p=0.508 | 0 |
| Short-term memory | 74.39 (16.99) | 62.30 (19.72) | t=3.884 p=0.01 | 0.7 |
| Nonverbal memory | 66.96 (19.80) | 68.99 (20.15) | t=-0.601 p=0.508 | 0.23 |
| Short-term visual memory | 69.80 (18.70) | 65.27 (21.01) | t=1.347 p=0.180 | 0.30 |
| Working memory | 75.57 (17.83) | 62.67 (18.51) | t=4.285 p=0.01 | 0.7 |
| Divided attention | 76.99 (15.78) | 72.37 (15.33) | t=1.766 p=0.080 | 0.13 |
| Focused attention | 86.84 (11.52) | 72.07 (14.45) | t=5.911 p=0.01 | 1.1 |
| Inhibition | 72.16 (15.13) | 71.06 (19.69) | t=0.371 p=0.711 | 0.06 |
| Monitoring | 69.63 (21.72) | 66.60 (23.32) | t=0.795 p=0.428 | 0 |
| Eye-hand coordination | 67.06 (19.63) | 61.40 (22.38) | t=1.590 p=0.114 | 0.27 |
| Response time | 79.97 (12.94) | 72.81 (14.53) | t=3.077 p=0.01 | 0.5 |
| Auditory perception | 70.99 (20.92) | 65.64 (22.78) | t=1.446 p=0.151 | -1.13 |
| Estimation | 62.80 (25.47) | 56.79 (30.39) | t=1.269 p=0.207 | 0.04 |
| Recognition | 69.20 (23.78) | 63.01 (22.82) | t=1.570 p=0.119 | 0.23 |
| Spatial perception | 61.29 (25.78) | 53.99 (30.92) | t=1.517 p=0.132 | 0.27 |
| Visual perception | 73.40 (22.48) | 64.73 (24.40) | t=2.187 p=0.030 | 0.4 |
| Visual scanning | 77.96 (17.22) | 80.09 (18.60) | t=-0.703 p=0.483 | 0.40 |
In the attentional domain, significant differences were also identified in focused attention (72.07 ± 14.45 vs. 86.84 ± 11.52; p = .01, d = 1.1) and response time (72.81 ± 14.53 vs. 79.97 ± 12.94; p = 0.01, d = 0.5), suggesting alterations in the efficiency and sustainability of attentional processes. Finally, the visual perception domain showed a lower score in the group with depression (64.73 ± 24.40) than in the group without symptoms (73.40 ± 22.48; p = 0.03, d = 0.4). In contrast, other domains such as cognitive flexibility, nonverbal memory, inhibition, naming, and monitoring did not show statistically significant differences between the groups (Table 4).
Cognition-ERP correlation
Convergent evidence has emerged between cognitive and electrophysiological domains. Prolonged ERP latencies (particularly P300) were negatively correlated with performance in processing speed (r = -0.39, p < 0.001), focused attention (r = -0.32, p < 0.001), and delayed recall (r = -0.31, p < 0.001). Similarly, reduced P300 amplitude correlated positively with visuospatial and auditory perception (r ≈ 0.30, p < 0.001), suggesting that more efficient sensory integration is associated with stronger cortical responses, are summarized in Table 5. Notably, the correlation between processing speed and P300 latency was stronger in the control group (r = -0.46, p < 0.001) than in the depression group (r = -0.28, p = 0.015), indicating a decoupling between behavioral and neural efficiency among students with depressive symptoms.
Table 5. Summary of significant ERP-cognition associations for P300 latency and amplitude.
ERP = event-related potential; r = Pearson correlation coefficient. All p-values are two-tailed.
| ERP measure | Direction of association | Cognitive domain | Correlation (r) | p-value | Interpretation |
| P300 latency | Negative | Processing speed | −0.39 | <0.001 | Longer latencies associated with poorer processing speed. |
| Negative | Focused attention | −0.32 | <0.001 | Delayed neural processing linked to reduced attentional efficiency. | |
| Negative | Delayed recall | −0.31 | <0.001 | Slower stimulus evaluation associated with poorer memory retrieval. | |
| P300 amplitude | Positive | Visuospatial perception | 0.278 | <0.001 | Greater amplitude reflects stronger perceptual integration. |
| Positive | Auditory perception | 0.305 | <0.001 | Higher cortical responsiveness linked to better auditory perceptual processing. |
Table 6 summarizes the significant Pearson correlation coefficients between ERP components (N100, N200, P300) and performance across cognitive domains (e.g., MoCA subscales, processing speed, memory, attention, perception). Negative correlations indicate that longer ERP latencies or reduced amplitudes are associated with poorer cognitive functioning. Only statistically significant associations (p < 0.05) are shown.
Table 6. Correlations between ERP parameters and cognitive measures in students with and without depressive symptoms.
Pearson correlation coefficients (r) and corresponding p-values are presented for participants with and without depressive symptoms. Negative correlations indicated lower cognitive performance associated with increased ERP amplitude or prolonged latency; positive correlations indicated better performance with greater cortical activation. Significant values are indicated in bold (p < 0.05).
ERP = event-related potential; MoCA = Montreal Cognitive Assessment.
| ERP measure | Cognitive domain | With depressive symptoms | Without depressive symptoms | ||
| – | – | Pearson correlation coefficients (r) | p-value | Pearson correlation coefficients (r) | p-value |
| N100 amplitude | MoCA attention | -0.327 | <0.001 | 0.394 | < 0.001 |
| MoCA total score | -0.290 | <0.001 | 0.379 | < 0.001 | |
| Processing speed | -0.208 | 0.014 | 0.117 | 0.886 | |
| Divided attention | -0.200 | 0.018 | 0.208 | 0.082 | |
| Response time | -0.196 | 0.020 | 0.112 | 0.351 | |
| Focused attention | -0.191 | 0.024 | 0.131 | 0.067 | |
| Estimation | 0.167 | 0.049 | 0.305 | 0.01 | |
| N100 latency | Contextual memory | -0.326 | <0.001 | -0.161 | 0.181 |
| Processing speed | -0.295 | <0.001 | -0.003 | 0.784 | |
| Hand-eye coordination | -0.291 | <0.001 | -0.019 | 0.873 | |
| Focused attention | -0.287 | <0.001 | -0.104 | 0.388 | |
| Working memory | -0.261 | 0.002 | -0.186 | 0.121 | |
| Visual perception | -0.260 | 0.002 | -0.202 | 0.091 | |
| Spatial perception | -0.247 | 0.003 | -0.019 | 0.871 | |
| Auditory perception | -0.237 | 0.005 | -0.141 | 0.243 | |
| Estimation | -0.227 | 0.007 | -0.215 | 0.073 | |
| MoCA delayed recall | -0.187 | 0.027 | 0.189 | 0.116 | |
| Response time | -0.185 | 0.029 | -0.046 | 0.070 | |
| Recognition | -0.181 | 0.033 | -0.061 | 0.610 | |
| Naming | -0.167 | 0.048 | -0.242 | 0.043 | |
| N200 amplitude | MoCA total score | -0.238 | 0.005 | 0.393 | <0.001 |
| MoCA delayed recall | -0.230 | 0.006 | 0.215 | 0.073 | |
| MoCA attention | -0.220 | 0.009 | 0.332 | <0.001 | |
| Response time | -0.180 | 0.034 | 0.132 | 0.034 | |
| MoCA orientation | 0.167 | 0.049 | 0.208 | 0.273 | |
| N200 latency | Focused attention | -0.337 | <0.001 | -0.035 | 0.769 |
| Contextual memory | -0.317 | <0.001 | -0.157 | 0.192 | |
| Processing speed | -0.304 | <0.001 | -0.005 | 0.096 | |
| Spatial perception | -0.254 | 0.002 | -0.206 | 0.086 | |
| Estimation | -0.222 | 0.009 | -0.117 | 0.209 | |
| Short-term phonological memory | -0.221 | 0.009 | -0.186 | 0.121 | |
| Hand-eye coordination | -0.181 | 0.032 | -0.135 | 0.263 | |
| MoCA abstraction | 0.207 | 0.014 | -0.088 | 0.467 | |
| P300 amplitude | MoCA visuospatial/executive | -0.272 | 0.001 | -0.105 | 0.384 |
| MoCA total score | -0.228 | 0.007 | 0.241 | 0.044 | |
| MoCA attention | -0.188 | 0.026 | 0.251 | 0.036 | |
| MoCA language | -0.187 | 0.027 | -0.041 | 0.735 | |
| MoCA naming | 0.169 | 0.045 | 0.188 | 0.118 | |
| Nonverbal memory | 0.173 | 0.041 | 0.157 | 0.193 | |
| Cognitive flexibility | 0.193 | 0.022 | 0.264 | 0.027 | |
| Short-term memory | 0.195 | 0.021 | 0.183 | 0.127 | |
| Short-term phonological memory | 0.197 | 0.020 | 0.139 | 0.250 | |
| Recognition | 0.203 | 0.016 | 0.299 | 0.097 | |
| Naming | 0.214 | 0.011 | 0.255 | 0.087 | |
| Inhibition | 0.218 | 0.010 | 0.238 | 0.047 | |
| Working memory | 0.262 | 0.002 | 0.315 | 0.007 | |
| Visual perception | 0.278 | <0.001 | 0.309 | 0.009 | |
| Auditory perception | 0.305 | <0.001 | 0.377 | < 0.001 | |
| Contextual memory | 0.308 | <0.001 | 0.245 | 0.041 | |
| Hand-eye coordination | 0.314 | <0.001 | 0.253 | 0.034 | |
| Estimation | 0.351 | <0.001 | 0.340 | 0.003 | |
| Spatial perception | 0.352 | <0.001 | 0.285 | 0.016 | |
| P300 latency | Processing speed | -0.385 | <0.001 | -0.072 | 0.553 |
| MoCA delayed recall | -0.317 | <0.001 | -0.090 | 0.454 | |
| Focused attention | -0.315 | <0.001 | -0.109 | 0.336 | |
| Contextual memory | -0.313 | <0.001 | 0.017 | 0.088 | |
| Response time | -0.207 | 0.014 | 0.053 | 0.661 | |
| Auditory perception | -0.196 | 0.020 | 0.151 | 0.209 | |
| Recognition | -0.177 | 0.036 | 0.231 | 0.054 | |
| Short-term phonological memory | -0.173 | 0.041 | 0.186 | 0.121 | |
| Working memory | -0.173 | 0.041 | 0.069 | 0.566 | |
| MoCA abstraction | 0.214 | 0.011 | 0.088 | 0.467 | |
Negative correlations between ERP measures and MoCA attention scores appeared in both the depressive-symptom and control groups, indicating a shared neurocognitive pattern in which greater cortical activation during attentional processing corresponds to lower performance. This suggests that an increased amplitude or prolonged latency reflects compensatory neural effort rather than enhanced efficiency. Importantly, these associations were consistently stronger in participants with depressive symptoms, indicating to a heightened vulnerability to neural inefficiency when attentional resources were challenged.
Discussion
This study demonstrated that medical students with depressive symptoms exhibit specific cognitive impairments-particularly slowed information processing, reduced attentional efficiency, and executive dysfunction, as reflected in both behavioral performance and electrophysiological patterns. The combination of prolonged latencies and reduced amplitudes across ERP components (N100, N200, and P300) suggests disruptions in the neural mechanisms supporting attention and cognitive control. These findings reinforce previous evidence that depressive symptoms, even at subclinical levels, are associated with measurable inefficiencies in cognitive processing.
Neurophysiological correlates (ERPs)
The consistent prolongation of latencies and reduction in amplitudes across ERP components reflect slower neural processing and reduced allocation of attentional resources. Previous studies have shown that changes in P300 latency in MDD reflect less efficient information-processing strategies, which translate into slower attentional processing [27,37-39]. Furthermore, decreased P300 amplitude has been associated with impaired perception of environmental stimuli and allocation of cognitive resources [40]. The attenuated association between processing speed and P300 latency in students with depression suggests a decoupling of behavioral and neural efficiency, consistent with disrupted cognitive control mechanisms [41-43].
Integration with cognitive findings
The MoCA findings revealed modest decrements in abstraction and delayed recall, whereas CogniFit identified broader deficits in planning, working memory, and attentional control. These results align with previous evidence that depression preferentially affects higher-order processes [4,39]. The convergence between neuropsychological and electrophysiological data strengthens the interpretation that depression compromises complex reasoning, flexible attention, problem-solving abilities, and academic performance [8].
Academic and professional implications
Cognitive and electrophysiological alterations identified in medical students with depressive symptoms should be interpreted with caution. Although differences were observed in processing speed, executive function, and memory, the study did not assess academic performance or clinical competence; therefore, no direct implications for educational outcomes or future professional practice can be inferred. Instead, these results suggest the presence of neurocognitive patterns associated with depressive symptoms, which warrant further examination. Early identification through digital neuropsychological tools and electrophysiological markers such as the P300 may help characterize these patterns more precisely; however, these associations remain correlational, and their relevance to academic or functional outcomes can only be clarified through longitudinal research. Although approaches such as cognitive training, structured physical exercise, and neuromodulation-based interventions have shown promise in improving executive functioning [44], establishing their specific applicability to students with depressive symptoms requires prospective studies that directly assess changes over time. Likewise, although the P300 component has been proposed as a potential translational biomarker for monitoring treatment effects [41,42], its clinical utility remains contingent on systematic validation in well-designed longitudinal investigations.
This study had methodological strengths. First, the multimodal design (integrating self-report measures, neuropsychological performance, and electrophysiological markers) provided a more comprehensive characterization of the cognitive patterns associated with depressive symptoms in medical students. Second, all assessments were conducted under controlled laboratory conditions, which likely enhanced the reliability of both cognitive and ERPs recordings by minimizing environmental and measurement variabilities.
Limitations and future directions
This study has several limitations. The cross-sectional design prevents causal inference, and recruitment from a single university limits the generalizability of the findings. Moreover, the sample consisted exclusively of second-year medical students; therefore, the results may not be applicable to students in other stages of medical training or to those enrolled in dental or allied health programs. Future studies should include multiple academic years and a broader range of health professions to better capture developmental and curricular influences on cognitive and electrophysiological functioning. The cognitive alterations identified here, primarily involving processing speed, executive functions (planning and working memory), and memory, should be explored further using longitudinal and multicenter designs. Incorporating complementary methods, such as neuroimaging or multimodal biomarkers, may help clarify the evolution and functional significance of these cognitive and neural features in students with depressive symptoms.
Conclusions
In the context of medical training, the cognitive and electrophysiological differences observed in students with depressive symptoms underscore the importance of identifying early signs of cognitive vulnerability. By integrating digital cognitive assessments with electrophysiological measures, this study offers a multidimensional perspective on how depressive symptoms relate to cognitive functioning among in medical students. Further research is needed to clarify how these cognitive and neural patterns evolve over time and determine their potential relevance to educational outcomes.
Funding Statement
This article is part of the research project PAPIIT IA207824, for which the corresponding author serves as the principal investigator. This study did not receive additional financial support from public, commercial, or not-for-profit funding agencies.
Disclosures
Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Committee on Ethics and Research, National Autonomous University of Mexico issued approval FM/DI/056/2021.
Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:
Payment/services info: This article is part of the research project PAPIIT IA207824, for which the corresponding author serves as the principal investigator. This study did not receive additional financial support from public, commercial, or not-for-profit funding agencies.
Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.
Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Author Contributions
Concept and design: Diana Guízar-Sánchez, Ricardo Jesús Martínez-Tapia, Arantza Martínez-Zarraluqui
Acquisition, analysis, or interpretation of data: Diana Guízar-Sánchez, Ricardo Jesús Martínez-Tapia, Raúl Sampieri-Cabrera
Drafting of the manuscript: Diana Guízar-Sánchez, Ricardo Jesús Martínez-Tapia, Raúl Sampieri-Cabrera, Arantza Martínez-Zarraluqui
Critical review of the manuscript for important intellectual content: Diana Guízar-Sánchez, Ricardo Jesús Martínez-Tapia, Raúl Sampieri-Cabrera, Arantza Martínez-Zarraluqui
Supervision: Diana Guízar-Sánchez
References
- 1.Depression is the leading cause of disability around the world. Friedrich MJ. JAMA. 2017;317:1517. doi: 10.1001/jama.2017.3826. [DOI] [PubMed] [Google Scholar]
- 2.Cognitive impairment in patients with depression: awareness, assessment, and management. Culpepper L, Lam RW, McIntyre RS. J Clin Psychiatry. 2017;78:1383–1394. doi: 10.4088/JCP.tk16043ah5c. [DOI] [PubMed] [Google Scholar]
- 3.Cognitive dysfunctions in depression - significance, description and treatment prospects. Czerwińska A, Pawłowski T. Psychiatr Pol. 2020;54:453–466. doi: 10.12740/PP/OnlineFirst/105415. [DOI] [PubMed] [Google Scholar]
- 4.Neurocognitive deficits in depression: a systematic review of cognitive impairment in the acute and remitted state. Kriesche D, Woll CF, Tschentscher N, Engel RR, Karch S. Eur Arch Psychiatry Clin Neurosci. 2023;273:1105–1128. doi: 10.1007/s00406-022-01479-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Functional and cognitive impairment in the first episode of depression: a systematic review. Varghese S, Frey BN, Schneider MA, Kapczinski F, de Azevedo Cardoso T. Acta Psychiatr Scand. 2022;145:156–185. doi: 10.1111/acps.13385. [DOI] [PubMed] [Google Scholar]
- 6.Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Conradi HJ, Ormel J, de Jonge P. Psychol Med. 2011;41:1165–1174. doi: 10.1017/S0033291710001911. [DOI] [PubMed] [Google Scholar]
- 7.Differences in cognitive deficits and brain functional impairments between patients with first-episode and recurrent depression. Guan L, Li Y, Kong H, et al. BMC Psychiatry. 2025;25:434. doi: 10.1186/s12888-025-06758-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Neuropsychological assessments of cognitive impairment in major depressive disorder: a systematic review and meta-analysis with meta-regression. Rhee TG, Shim SR, Manning KJ, et al. Psychother Psychosom. 2024;93:8–23. doi: 10.1159/000535665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Cognitive decline and its associated factors in patients with major depressive disorder. Ab Latiff HZ, Ariaratnam S, Shuib N, Isa MR. Healthcare (Basel) 2023;11 doi: 10.3390/healthcare11070950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Prevalence of depression, depressive symptoms, and suicidal ideation among medical students: a systematic review and meta-analysis. Rotenstein LS, Ramos MA, Torre M, et al. JAMA. 2016;316:2214–2236. doi: 10.1001/jama.2016.17324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Supporting the mental health and well-being of higher education students. [ Oct; 2025 ]. 2024. https://unesdoc.unesco.org/ark:/48223/pf0000391501 https://unesdoc.unesco.org/ark:/48223/pf0000391501
- 12.Exploring the impact of depression, anxiety, stress, academic engagement, and dropout intention on medical students' academic performance: A prospective study. Sinval J, Oliveira P, Novais F, Almeida CM, Telles-Correia D. J Affect Disord. 2025;368:665–673. doi: 10.1016/j.jad.2024.09.116. [DOI] [PubMed] [Google Scholar]
- 13.The interplay between mindfulness, depression, stress and academic performance in medical students: a Saudi perspective. Alzahrani AM, Hakami A, AlHadi A, Batais MA, Alrasheed AA, Almigbal TH. PLoS One. 2020;15:0. doi: 10.1371/journal.pone.0231088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Depressive symptoms and burnout among medical students: a prospective study. Ranasinghe PD, Owusu JT, Bertram A, et al. J Gen Intern Med. 2022;37:64–69. doi: 10.1007/s11606-021-06765-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Working memory training for reward processing in university students with subsyndromal depression: the influence of baseline severity of depression. Hou L, Long F, Zhou W, Zhou R. https://doi.org/10.1016/j.biopsycho.2023.108710. Biol Psychol. 2023;184:108710. doi: 10.1016/j.biopsycho.2023.108710. [DOI] [PubMed] [Google Scholar]
- 16.Mental health and cognitive function among medical students after the COVID-19 pandemic in China. Cheng J, Liao M, He Z, et al. https://doi.org/10.3389/fpubh.2023.1233975. Front Public Health. 2023;11:1233975. doi: 10.3389/fpubh.2023.1233975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Synapse-related serum and P300 biomarkers predict the occurrence of mild cognitive impairment in depression. Xue Z, Zhu X, Wu W, Zhu Y, Xu Y, Yu M. https://doi.org/10.2147/NDT.S448312. Neuropsychiatr Dis Treat. 2024;20:493–503. doi: 10.2147/NDT.S448312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Standardized treatment and shortened depression course can reduce cognitive impairment in adolescents with depression. Cao P, Tan J, Liao X, Wang J, Chen L, Fang Z, Pan N. https://doi.org/10.5765/jkacap.230052. J Korean Acad Child Adolesc Psychiatry. 2024;35:90–97. doi: 10.5765/jkacap.230052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Assessing neurocognition (P300) and correlating them to depression rating scales in patients with major depressive disorder. Wakode S, Hulke S, Wakode NS, Pathak T, Shrivastava R, Thakare A, Malhotra V. Cureus. 2022;14:0. doi: 10.7759/cureus.31084. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Systematic review and meta-analysis: impact of unipolar depression on P300 amplitude and latency. Santopetro NJ, Thompson B, Garron A, Keith L, Brush CJ, Schmidt B, Hajcak G. https://doi.org/10.1016/j.neubiorev.2025.106230. Neurosci Biobehav Rev. 2025;175:106230. doi: 10.1016/j.neubiorev.2025.106230. [DOI] [PubMed] [Google Scholar]
- 21.The association of cognitive deficits with mental and physical quality of life in major depressive disorder. Knight MJ, Lyrtzis E, Baune BT. https://doi.org/10.1016/j.comppsych.2019.152147. Compr Psychiatry. 2020;97:152147. doi: 10.1016/j.comppsych.2019.152147. [DOI] [PubMed] [Google Scholar]
- 22.Prevalence, characteristics and measurement of somatic symptoms related to mental health in medical students: a scoping review. Sperling EL, Hulett JM, Sherwin LB, Thompson S, Bettencourt BA. Ann Med. 2023;55:2242781. doi: 10.1080/07853890.2023.2242781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Electrophysiological and neuropsychological assessment of cognition in spinocerebellar ataxia type 1 patients: a pilot study. Contaldi E, Sensi M, Colucci F, et al. https://doi.org/10.1007/s10072-022-06597-5. Neurol Sci. 2023;44:1597–1606. doi: 10.1007/s10072-022-06597-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Cognitive impairment in the co-occurrence of alcohol dependence and major depression: neuropsychological assessment and event-related potentials analyses. Flores-Medina Y, Rodríguez-Agudelo Y, Bernal-Hernández J, Cruz-Fuentes CS. Heliyon. 2022;8:0. doi: 10.1016/j.heliyon.2022.e09899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Detection of suicide risk using event-related potentials: a comprehensive systematic review and meta-analysis. Yin Q, Xu H, Chen Z, Jiang Q, Liu T. Psychoradiology. 2025;5:0. doi: 10.1093/psyrad/kkaf018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Sleep efficiency and event-related potentials in patients with depression: the mediating role of serum C-reactive protein. Fang L, Wang P, Xie T, et al. Front Psychiatry. 2025;16:1574864. doi: 10.3389/fpsyt.2025.1574864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Auditory event-related potentials in separating patients with depressive disorders and non-depressed controls: a narrative review. Kangas ES, Vuoriainen E, Lindeman S, Astikainen P. Int J Psychophysiol. 2022;179:119–142. doi: 10.1016/j.ijpsycho.2022.07.003. [DOI] [PubMed] [Google Scholar]
- 28.Electrophysiological biomarkers and age characterize phenotypic heterogeneity among individuals with major depressive disorder. Key AP, Thornton-Wells TA, Smith DG. Front Hum Neurosci. 2022;16:1055685. doi: 10.3389/fnhum.2022.1055685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.The effects of an 8-week taekwondo exercise intervention on inhibitory control in university students with depressive symptoms demonstrated the following-evidence from behavior and ERPs. Yun S, Guo Z, Li S, et al. BMC Psychiatry. 2025;25:169. doi: 10.1186/s12888-025-06598-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.The PHQ-9: validity of a brief depression severity measure. Kroenke K, Spitzer RL, Williams JB. J Gen Intern Med. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Establishing reliability and validity for mental health screening instruments in resource-constrained settings: systematic review of the PHQ-9 and key recommendations. Carroll HA, Hook K, Perez OF, et al. https://doi.org/10.1016/j.psychres.2020.113. Psychiatry Res. 2020;291:113236. doi: 10.1016/j.psychres.2020.113236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.CogniFit. [ Oct; 2025 ]. https://www.cognifit.com https://www.cognifit.com
- 33.Technologies for cognitive training and cognitive rehabilitation for people with mild cognitive impairment and dementia. A systematic review. Irazoki E, Contreras-Somoza LM, Toribio-Guzmán JM, Jenaro-Río C, van der Roest H, Franco-Martín MA. https://doi.org/10.3389/fpsyg.2020.00648. Front Psychol. 2020;11:648. doi: 10.3389/fpsyg.2020.00648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Understanding digital dementia and cognitive impact in the current era of the internet: a review. Ali Z, Janarthanan J, Mohan P. Cureus. 2024;16:0. doi: 10.7759/cureus.70029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Cognitive decline monitoring through a web-based application. Sánchez-Vincitore LV, Cubilla-Bonnetier D, Marte-Santana H, Duñabeitia JA. https://doi.org/10.3389/fnagi.2023.1212496. Front Aging Neurosci. 2023;15:1212496. doi: 10.3389/fnagi.2023.1212496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Validity and reliability of the Spanish version of the Montreal Cognitive Assessment (MoCA) for the detection of cognitive impairment in Mexico. Aguilar-Navarro SG, Mimenza-Alvarado AJ, Palacios-García AA, Samudio-Cruz A, Gutiérrez-Gutiérrez LA, Ávila-Funes JA. Rev Colomb Psiquiatr (Engl Ed) 2018;47:237–243. doi: 10.1016/j.rcp.2017.05.003. [DOI] [PubMed] [Google Scholar]
- 37.P300 parameters in major depressive disorder: a systematic review and meta-analysis. Arıkan MK, İlhan R, Orhan Ö, et al. World J Biol Psychiatry. 2024;25:255–266. doi: 10.1080/15622975.2024.2321554. [DOI] [PubMed] [Google Scholar]
- 38.Cognitive psychophysiological substrates of affective temperaments. Poyraz BÇ, Sakallı Kani A, Aksoy Poyraz C, Öcek Baş T, Arıkan MK. Clin EEG Neurosci. 2017;48:96–102. doi: 10.1177/1550059416650112. [DOI] [PubMed] [Google Scholar]
- 39.Attenuated doors-locked P300 amplitude and elevated depressive symptoms: effects of age and sex in two independent samples of youth. Santopetro NJ, Amir N, Nelson BD, Klein DN, Hajcak G. Psychophysiology. 2025;62:0. doi: 10.1111/psyp.70009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.The P300 component of the auditory event-related potential in adult psychiatric and neurologic disorders: a narrative review of clinical and experimental evidence. Raggi A, Serretti A, Ferri R. Int Clin Psychopharmacol. 2025;40:259–274. doi: 10.1097/YIC.0000000000000566. [DOI] [PubMed] [Google Scholar]
- 41.P300 amplitude during a monetary incentive delay task predicts future therapy completion in individuals with major depressive disorder. White EJ, Nacke M, Akeman E, et al. J Affect Disord. 2021;295:873–882. doi: 10.1016/j.jad.2021.08.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Changes in P300 amplitude to negative emotional stimuli correlate with treatment responsiveness to sertraline in adolescents with depression. Zhao L, Zhou D, He X, et al. Brain Res. 2024;1845:149272. doi: 10.1016/j.brainres.2024.149272. [DOI] [PubMed] [Google Scholar]
- 43.A systematic review of executive function and information processing speed in major depression disorder. Nuño L, Gómez-Benito J, Carmona VR, Pino O. Brain Sci. 2021;11 doi: 10.3390/brainsci11020147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Neural mechanisms underlying cognitive impairment in depression and cognitive benefits of exercise intervention. Tian H, Wang Z, Meng Y, et al. Behav Brain Res. 2025;476:115218. doi: 10.1016/j.bbr.2024.115218. [DOI] [PubMed] [Google Scholar]

